Drug General Information
Drug ID
D0V2ER
Former ID
DNC009301
Drug Name
KNI-10080
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529771]
Structure
Download
2D MOL

3D MOL

Formula
C34H39N3O6S
Canonical SMILES
CC1=CC(=CC=C1)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=<br />O)NC4C(CC5=CC=CC=C45)O)(C)C)O
InChI
1S/C34H39N3O6S/c1-21-10-9-14-24(16-21)43-19-28(39)35-26(17-22-11-5-4-6-12-22)30(40)33(42)37-20-44-34(2,3)31(37)32(41)36-29-25-15-8-7-13-23(25)18-27(29)38/h4-16,26-27,29-31,38,40H,17-20H2,1-3H3,(H,35,39)(H,36,41)/t26-,27+,29-,30-,31+/m0/s1
InChIKey
LAVCSYCCYHZRBK-VFCPCCRCSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasmepsin 2 Target Info Inhibitor [529771]
References
Ref 529771Bioorg Med Chem. 2008 Dec 1;16(23):10049-60. Epub 2008 Oct 10.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Ref 529771Bioorg Med Chem. 2008 Dec 1;16(23):10049-60. Epub 2008 Oct 10.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.